Cargando…
Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells
Histone deacetylases (HDACs) play a key role in epigenetic mechanisms in health and disease and their dysfunction is implied in several cancer entities. Analysis of expression patterns in pancreatic neuroendocrine tumors (pNETs) indicated HDAC5 to be a potential target for future therapies. As a fir...
Autores principales: | Wanek, Julia, Gaisberger, Martin, Beyreis, Marlena, Mayr, Christian, Helm, Katharina, Primavesi, Florian, Jäger, Tarkan, Di Fazio, Pietro, Jakab, Martin, Wagner, Andrej, Neureiter, Daniel, Kiesslich, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213165/ https://www.ncbi.nlm.nih.gov/pubmed/30321986 http://dx.doi.org/10.3390/ijms19103128 |
Ejemplares similares
-
HDAC-Linked “Proliferative” miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors
por: Klieser, Eckhard, et al.
Publicado: (2018) -
The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics
por: Beyreis, Marlena, et al.
Publicado: (2019) -
Miniaturization of the Clonogenic Assay Using Confluence Measurement
por: Mayr, Christian, et al.
Publicado: (2018) -
Continuous, label-free, 96-well-based determination of cell migration using confluence measurement
por: Mayr, Christian, et al.
Publicado: (2018) -
HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer
por: Mayr, Christian, et al.
Publicado: (2021)